The company, which reports its quarterly earnings Tuesday, has once again become an investor favorite.
VIDEO ON MSN MONEY
Cirrus Logic is downgraded to 'perform,' and Infosys is upgraded to 'buy.'
Digitizing health care data is revolutionizing the industry, and these companies are top plays on this trend.
The reasoning behind converting to electronic medical records is simple: efficiency. Digital records will help end medical errors, stop unnecessary tests and eliminate the danger of improper drug interaction -- all while streamlining workloads, decreasing paperwork and lowering costs.
Computerized records can revolutionize the industry, just as they did for banking and retail. And Athenahealth (ATHN) and Allscripts (MDRX) are my favorite software plays on this market.
The Crown Imports deal is a major coup, but STZ still has issues.
By Charles Sizemore
It's not often that a stock with a $5 billion market cap soars by more than 20% in a single trading day, but such was the case Friday for Constellation Brands (STZ), the largest publicly traded wine merchant, and now the sole distributor in the United States of Corona and Grupo Modelo's (GPMCF) other Mexican beer brands.
Constellation was the unexpected winner in the Anheuser-Busch InBev (BUD) deal to buy the controlling stake in Grupo Modelo, as Constellation was able to buy out Bud's 50% share of the companies' Crown Imports joint venture for $1.8 billion.
Google unveils big improvements for the next iteration of its mobile OS.
Jelly Bean upholds the Android tradition of food-related naming conventions, and is "fast, slick, and feels like what [Android 4.0] Ice Cream Sandwich" should have been when it launched half a year ago, says Armando Rodriguez at PC World.
The diabetes drugmaker is being acquired, and the chairman of the financial firm is resigning.
Bristol-Myers Squibb (BMY) is purchasing diabetes drugmaker Amylin Pharmaceuticals (AMLN) in a deal valued at about $7 billion. The companies said on Friday that Bristol-Myers would pay $31 a share in cash for San Diego-based Amylin. The deal includes Amylin's net debt and a payment obligation to Eli Lilly (LLY) bringing the total value of the transaction to about $7 billion, the companies said.
The purchase price offers a 9.9% premium of to Amylin's closing share price Friday of $28.20.
Shares of Amylin rose 8.94% in premarket trading Monday to $30.72.
Should the company exit the continent altogether? That's increasingly looking like a smart move.
The company is hurting badly outside of North America, to the point where its pretax operating profit in the second quarter will be substantially lower. Its pretax losses in Asia, South America and Europe may hit $570 million. To give you an idea of how quickly things are deteriorating, consider that pretax losses in those regions in the first quarter were only $190 million.
Even the participating national leaders seem a little confused about some of the outcomes.
The solar energy company expects to see higher sales in 2012 despite German headwinds.
Stocks remain up despite a low consumer confidence reading.
The Supreme Court decision could benefit some health stocks.
Thursday's 5-4 Supreme Court ruling upholding virtually all the provisions of President Barack Obama's controversial health care reform legislation was a big victory for the White House, and it could be a win for some health care stocks.
Shares of hospital companies like HCA Holdings (HCA) soared on the news. Now, finally, with all Americans required to obtain health insurance, there's a chance for hospitals to be paid for all the services they provide. Those uninsured patients who now turn to emergency rooms to provide treatment for what otherwise might be handled by a family physician may no longer be as much of a drain on the bottom line, and patients who defer treatment until an illness becomes critical for lack of insurance -- and who then can't pay their hospital bills -- may decline.
A better-than-expected deal out of the eagerly awaited eurozone summit has kicked off what could become a long rally.
Finally, Germany cedes a little, and markets go crazy. European leaders agreed to take steps toward closer budgetary controls and tighter political union. Moreover, in a victory for Europe's Latin Bloc, German Chancellor Angela Merkel opened to using bailout funds to directly recapitalize banks and to purchase sovereign bonds in the open market.
This is huge step forward, and markets are responding accordingly. By all indications, the gains are just getting started ahead of what could be a multimonth advance before worries over America's "fiscal cliff" -- tax hikes and spending cuts worth about 5% of GDP due to hit in early 2013 -- cause new weakness. Here's how to play it.
JPMorgan's hit from a single trade may reach $9 billion, casting doubt on its CEO's claims that the financial giant is safe and sound.
This week, The New York Times reported that JPMorgan Chase (JPM) could lose up to $9 billion on a single trade, a huge escalation from the already-massive $2 billion that CEO Jamie Dimon had initially estimated. When the botched trade was first disclosed in May, it stoked fears that Wall Street banks were engaging in the type of casino-style risk-taking that brought the financial system to its knees in 2008. But Dimon insisted -- notably during two congressional hearings -- that the trade was an isolated incident and that Main Street had nothing to fear.
The latest report from The Times casts doubt on that claim, with one former banking regulator telling the paper, "Essentially, JPMorgan has been operating a hedge fund" with the money in its customers' checking accounts. Is this proof that JPMorgan is a threat to the economy?
The BlackBerry maker is taking another beating after a terrible quarter and a major product delay.
Let's get right to the ugly headline facts and figures:
The US economy is still growing, though, so investors shouldn't panic.
MSN Money's Anthony Mirhaydari answers Facebook users' questions about the nation's debt crunch.
As he answers questions from MSN Money's Facebook community, Mirhaydari also discusses investments that do well in a debt hole environment, such as gold and other inflation hedges.
MORE ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
Pipeline owners are making big profits on oil coming from North Dakota's Bakken fields. But a lot of natural gas continues to be flared due to low prices.
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.
[BRIEFING.COM] The S&P 500 has extended its gain to 0.6% with the health care sector (+1.0%) remaining ahead of the other nine groups.
Unlike the health care space, all of the remaining countercyclical sectors trail the broader market. The telecom services sector (+0.1%) continues holding a slim gain with Verizon (VZ 50.83, +0.13) up 0.2% in reaction to its earnings beat, while consumer staples (-0.2%) and utilities (-0.02%) hover in the red.
Notably, the staples ... More
More Market News
|There’s a problem getting this information right now. Please try again later.|